South Boston, MA, United States of America

Walter Kowtoniuk

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fulcrum Therapeutics, Inc., University of Massachusetts. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walter Kowtoniuk. Retrieved from https://idiyas.com/inventor/walter-kowtoniuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walter Kowtoniuk: Innovator in Gene Modulation

Introduction

Walter Kowtoniuk is a notable inventor based in South Boston, MA (US). He has made significant contributions to the field of genetics, particularly in the modulation of gene expression. His work has implications for treating disorders associated with gene inactivation.

Latest Patents

Walter Kowtoniuk holds a patent titled "Compositions and methods for modulating FMR1 expression." This patent relates to methods and compositions aimed at reactivating a silenced FMR1 gene. The methods described in this patent are particularly useful for treating disorders associated with FMR1 inactivation, such as fragile X syndrome. He has 1 patent to his name.

Career Highlights

Throughout his career, Kowtoniuk has worked with esteemed institutions, including the University of Massachusetts and Fulcrum Therapeutics, Inc. His research has focused on innovative approaches to gene therapy and modulation.

Collaborations

Walter has collaborated with prominent scientists in his field, including Michael R. Green and Minggang Fang. These collaborations have furthered the understanding and development of gene modulation techniques.

Conclusion

Walter Kowtoniuk's contributions to gene modulation and his innovative patent work highlight his role as a significant figure in the field of genetics. His research continues to pave the way for advancements in treating genetic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…